Botanix Pharmaceuticals
  • Home
  • About
  • Technology
  • Pipeline
  • Sofpironium Bromide
  • Clinical Trials
  • Invest
  • News
  • Contact
  • Search
  • Menu Menu
  • Facebook
  • LinkedIn
  • Twitter
  • Youtube
News

Botanix announces landmark descheduling of synthetic CBD by DEA

November 25, 2019/in Latest News /by administrator
Source:
The Green Fund
https://thegreenfund.com/botanix-announces-de-scheduling-of-synthetic-cbd-by-the-dea

/wp-content/uploads/botanix-logo.png 0 0 administrator /wp-content/uploads/botanix-logo.png administrator2019-11-25 11:17:002020-07-07 11:20:00Botanix announces landmark descheduling of synthetic CBD by DEA

Categories

  • ASX Releases
  • Featured
  • Journal Articles
  • Latest News
  • News
  • Presentations
  • Videos

Social

Facebook
LinkedIn
Twitter
Youtube

Where to find us

AUSTRALIA

Level 1, 50 Angove Street, North Perth WA 6006

USA

3602 Horizon Drive, Suite 160, King of Prussia, PA 19406

Subscribe

Be notified of important news from Botanix.

Subscribe

Contact us

AU +61 8 6555 2945
US + 1 445 300 3403
info@botanixpharma.com

© Copyright - Botanix Pharmaceuticals
  • Legal notice
Updates on 3 Health Care Stocks – Allegra, Althea and Botanix Exploring CBD’s newly found antibacterial properties
Scroll to top